These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 20174572

  • 1. Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.
    Blanco-Aparicio C, Cañamero M, Cecilia Y, Pequeño B, Renner O, Ferrer I, Carnero A.
    PLoS One; 2010 Feb 19; 5(2):e9305. PubMed ID: 20174572
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA.
    Nat Cell Biol; 2007 May 19; 9(5):493-505. PubMed ID: 17450133
    [Abstract] [Full Text] [Related]

  • 3. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.
    Belguise K, Sonenshein GE.
    J Clin Invest; 2007 Dec 19; 117(12):4009-21. PubMed ID: 18037997
    [Abstract] [Full Text] [Related]

  • 4. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.
    Schmidt JW, Wehde BL, Sakamoto K, Triplett AA, Anderson SM, Tsichlis PN, Leone G, Wagner KU.
    Mol Cell Biol; 2014 Apr 19; 34(7):1363-77. PubMed ID: 24469394
    [Abstract] [Full Text] [Related]

  • 5. Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.
    Cheng X, Xia W, Yang JY, Hsu JL, Lang JY, Chou CK, Du Y, Sun HL, Wyszomierski SL, Mills GB, Muller WJ, Yu D, Hung MC.
    Cancer Res; 2010 Oct 01; 70(19):7684-9. PubMed ID: 20841468
    [Abstract] [Full Text] [Related]

  • 6. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ.
    Mol Cell Biol; 2001 Mar 01; 21(6):2203-12. PubMed ID: 11238953
    [Abstract] [Full Text] [Related]

  • 7. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
    Renner O, Blanco-Aparicio C, Grassow M, Cañamero M, Leal JF, Carnero A.
    Cancer Res; 2008 Dec 01; 68(23):9643-53. PubMed ID: 19047141
    [Abstract] [Full Text] [Related]

  • 8. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
    Shibata MA, Maroulakou IG, Jorcyk CL, Gold LG, Ward JM, Green JE.
    Cancer Res; 1996 Jul 01; 56(13):2998-3003. PubMed ID: 8674054
    [Abstract] [Full Text] [Related]

  • 9. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
    Mancini ML, Lien EC, Toker A.
    Oncotarget; 2016 Apr 05; 7(14):17301-13. PubMed ID: 27004402
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H, Cui Y, Dupont J, Sun H, Hennighausen L, Yakar S.
    Cancer Res; 2005 Aug 01; 65(15):6864-73. PubMed ID: 16061670
    [Abstract] [Full Text] [Related]

  • 11. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.
    Adams JR, Xu K, Liu JC, Agamez NM, Loch AJ, Wong RG, Wang W, Wright KL, Lane TF, Zacksenhaus E, Egan SE.
    Cancer Res; 2011 Apr 01; 71(7):2706-17. PubMed ID: 21324922
    [Abstract] [Full Text] [Related]

  • 12. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.
    Exp Mol Pathol; 2001 Jun 01; 70(3):183-93. PubMed ID: 11417997
    [Abstract] [Full Text] [Related]

  • 13. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G, Rosner A, Han Y, Zelazny ET, Li B, Cardiff RD, Perkins AS.
    Am J Pathol; 2002 Dec 01; 161(6):2241-53. PubMed ID: 12466138
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.
    Cancer Res; 2007 Aug 01; 67(15):7212-22. PubMed ID: 17671189
    [Abstract] [Full Text] [Related]

  • 15. The DNA resection protein CtIP promotes mammary tumorigenesis.
    Reczek CR, Shakya R, Miteva Y, Szabolcs M, Ludwig T, Baer R.
    Oncotarget; 2016 May 31; 7(22):32172-83. PubMed ID: 27058754
    [Abstract] [Full Text] [Related]

  • 16. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.
    Watson KL, Moorehead RA.
    BMC Cancer; 2013 Aug 07; 13():375. PubMed ID: 23919516
    [Abstract] [Full Text] [Related]

  • 17. Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
    Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, Allred DC, McCarthy M, Ullrich RL.
    FASEB J; 2002 Jun 07; 16(8):881-3. PubMed ID: 11967232
    [Abstract] [Full Text] [Related]

  • 18. Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.
    Díaz-Cruz ES, Furth PA.
    Cancer Res; 2010 May 15; 70(10):3965-74. PubMed ID: 20466998
    [Abstract] [Full Text] [Related]

  • 19. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
    Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ.
    Cancer Res; 2004 May 01; 64(9):3171-8. PubMed ID: 15126356
    [Abstract] [Full Text] [Related]

  • 20. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands.
    Seigne C, Auret M, Treilleux I, Bonnavion R, Assade F, Carreira C, Goddard-Léon S, Lavergne E, Chabaud S, Garcia A, Mazoyer S, Lu J, Bachelot T, Frappart L, Zhang CX.
    J Pathol; 2013 Mar 01; 229(4):546-58. PubMed ID: 23180448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.